Type 1 diabetes (T1D) is a lifelong autoimmune disorder where the immune system attacks islets, certain areas of the pancreas ...

Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks the cells that produce insulin—a critical hormone that regulates blood sugar in the body. Scientists at Scripps ...

Researchers at Stanford Medicine have reported a breakthrough in Type 1 diabetes research after successfully curing the disease in mice using a new method designed to “reset” the immune system. The ...

Today millions of diabetic patients across the world do not have access to insulin. Why and how can governments reverse this ...

More than a decade ago, researchers found that an acute complication of type 1 diabetes, diabetic ketoacidosis (DKA), can be resolved with the hormone leptin, even in the absence of insulin. DKA ...

Forbes contributors publish independent expert analyses and insights. Juergen Eckhardt leads Bayer’s impact investment unit, Leaps by Bayer. As a venture investor in healthcare, I am privileged to ...

A life-changing treatment that delays the onset of oppressive type 1 diabetes symptoms, and the need for insulin injections, ...

With better screening for type 1 diabetes and a new treatment called TZield, the outlook is improving for people with the autoimmune disease.

This article is part of “Innovations In: Type 1 Diabetes,” an editorially independent special report that was produced with financial support from Vertex. On one wall of endocrinologist Kevan Herold’s ...

Identifying children with early signs of type 1 diabetes makes a difference to their health. A new study suggests wider screening is effective.

Once known as “juvenile” diabetes, type 1 diabetes was long considered a childhood disease. Although the condition is often diagnosed in children and teenagers, it can develop at any age. Type 1 ...